Adverum Biotechnologies, Inc.
NASDAQ:ADVM
4.74 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 75 | 68.431 | 34.195 | 62.424 | 65.897 | 154.949 | 70.519 | 222.17 | 259.08 | 159.404 | 0.564 | 0.357 |
| Short Term Investments
| 21.526 | 117.158 | 270.993 | 367.305 | 100.138 | 50.13 | 119.966 | 0 | 37.732 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 96.526 | 185.589 | 305.188 | 429.729 | 166.035 | 205.079 | 190.485 | 222.17 | 259.08 | 159.404 | 0.564 | 0.357 |
| Net Receivables
| 0 | 0 | 5.709 | 0 | 0 | 0 | 0 | 0.886 | 0.449 | 0 | 0.008 | 0.001 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.247 | 5.006 | 6.248 | 9.418 | 19.67 | 7.35 | 6.512 | 2.218 | 1.463 | 1.748 | 0.25 | 0.024 |
| Total Current Assets
| 102.773 | 190.595 | 317.145 | 434.438 | 175.87 | 208.754 | 193.741 | 225.274 | 260.992 | 160.278 | 0.822 | 0.382 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 67.03 | 113.861 | 119.06 | 47.101 | 45.847 | 3.586 | 3.024 | 4.169 | 3.187 | 1.085 | 0.069 | 0.004 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 5 | 5 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.976 | 2.503 | 3.272 | 0.999 | 0.999 | 0.999 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.231 | 1.413 | 0.25 | 0.029 | 0.011 | 0.156 | 0.14 | 0.14 | 0.14 | 0.543 | 0.194 | 0 |
| Total Non-Current Assets
| 70.237 | 117.777 | 122.582 | 48.129 | 46.857 | 4.741 | 8.164 | 9.309 | 3.327 | 1.628 | 0.263 | 0.004 |
| Total Assets
| 173.01 | 308.372 | 439.727 | 482.567 | 222.727 | 213.495 | 201.905 | 234.583 | 264.319 | 161.906 | 1.085 | 0.386 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 1.921 | 2.238 | 1.387 | 2.81 | 4.103 | 1.707 | 1.731 | 1.474 | 0.605 | 0.951 | 0.769 | 0.522 |
| Short Term Debt
| 20.818 | 26.482 | 3.772 | 8.946 | 4.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0.101 | 0.254 | 1.318 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -6.087 | 0 | 16.03 | 12.263 | 8.635 | -0.1 | 1.85 | 1.85 | 0.883 | 0.813 | 0 | 0 |
| Other Current Liabilities
| 2.074 | 3.272 | 14.843 | 9.075 | 11.271 | 9.012 | 7.093 | 6.572 | 5.086 | 3.707 | 0.393 | 0.317 |
| Total Current Liabilities
| 24.914 | 32.246 | 21.32 | 20.871 | 19.408 | 10.719 | 10.674 | 9.896 | 6.574 | 5.471 | 1.162 | 0.839 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 64.627 | 93.561 | 101.108 | 26.235 | 28.214 | 0.2 | 0 | 0 | 0 | 0 | 0.091 | 0.521 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 5.25 | 7.099 | 4.706 | 6.646 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 1.25 | 1.25 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 1.047 | 1.114 | 1.114 | 0.148 | 1.409 | 0.703 | 0.738 | 0.447 | 0.306 | 0.05 | 0.023 |
| Total Non-Current Liabilities
| 64.627 | 94.608 | 102.222 | 27.349 | 28.362 | 1.609 | 7.203 | 9.087 | 5.153 | 6.952 | 0.141 | 0.544 |
| Total Liabilities
| 89.541 | 126.854 | 123.542 | 48.22 | 47.77 | 12.328 | 17.877 | 18.983 | 11.727 | 12.423 | 1.303 | 1.383 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 161.906 | 7.992 | 2.471 |
| Common Stock
| 0.01 | 0.01 | 0.01 | 0.01 | 0.007 | 0.006 | 0.005 | 0.004 | 0.003 | 0.002 | 0 | 0 |
| Retained Earnings
| -919.777 | -802.612 | -648.076 | -502.536 | -385.029 | -320.543 | -254.062 | -197.915 | -84.168 | -36.715 | -8.869 | -3.593 |
| Accumulated Other Comprehensive Income/Loss
| -0.473 | -1.531 | -0.714 | -0.261 | -0.725 | -0.799 | -0.963 | -0.007 | -0.011 | 0.01 | 0.027 | 0.008 |
| Other Total Stockholders Equity
| 1,003.709 | 985.651 | 964.965 | 937.134 | 560.704 | 522.503 | 439.048 | 413.518 | 336.768 | 186.186 | 0.632 | 0.117 |
| Total Shareholders Equity
| 83.469 | 181.518 | 316.185 | 434.347 | 174.957 | 201.167 | 184.028 | 215.6 | 252.592 | 149.483 | -0.218 | -0.997 |
| Total Equity
| 83.469 | 181.518 | 316.185 | 434.347 | 174.957 | 201.167 | 184.028 | 215.6 | 252.592 | 149.483 | -0.218 | -0.997 |
| Total Liabilities & Shareholders Equity
| 173.01 | 308.372 | 439.727 | 482.567 | 222.727 | 213.495 | 201.905 | 234.583 | 264.319 | 161.906 | 1.085 | 0.386 |